Viewing Study NCT02153502


Ignite Creation Date: 2025-12-25 @ 3:54 AM
Ignite Modification Date: 2026-03-31 @ 2:09 PM
Study NCT ID: NCT02153502
Status: COMPLETED
Last Update Posted: 2017-05-15
First Post: 2014-05-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Sponsor: Avanir Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-07
Start Date Type: ACTUAL
Primary Completion Date: 2016-02
Primary Completion Date Type: ACTUAL
Completion Date: 2016-02
Completion Date Type: ACTUAL
First Submit Date: 2014-05-29
First Submit QC Date: None
Study First Post Date: 2014-06-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2017-05-15
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2017-05-11
Last Update Post Date: 2017-05-15
Last Update Post Date Type: ACTUAL